Teva Pharmaceutical Industries (TEVA) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Teva Pharmaceutical Industries, as the data feed reports them.

Analysts' mean target, 14 analysts
$50.29
18.0% above the price

The 14 analysts reported by the data feed have a mean price target for Teva Pharmaceutical Industries of $50.29, 18.0% above the $42.62 price (range $42.12–$57.00). 2.39% of the float was sold short as of Oct 30, 2026. Institutions hold 69.3% of the shares and insiders 0.5%. Source: Yahoo Finance, read Nov 18, 2026.

Key facts

Analysts' mean target
$50.29+18.0% vs price
Analysts
14
Short interest
2.39%of float, Oct 30, 2026
Short ratio
4.49 days
Institutions
69.3%
Insiders
0.48%
Beta
0.84
Next earnings
Jan 27, 2027estimated

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

14 analysts covering Teva Pharmaceutical Industries, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $42.62.

Analysts' price targets for Teva Pharmaceutical Industries
Mean price target$50.2918.0% above the price (+18.0%)
Median price target$49.5016.1% above the price (+16.1%)
Highest target$57.0033.7% above the price (+33.7%)
Lowest target$42.121.2% below the price (−1.2%)
Analysts with a target14

Ratings this month · 15 analysts

Strong buy 4(27%)Buy 9(60%)Hold 2(13%)
Analysts' ratings of Teva Pharmaceutical Industries this month, by rating
RatingAnalystsShare
Strong buy427%
Buy960%
Hold213%
Sell00%
Strong sell00%

The feed averages these to 1.53 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “buy”.

Who owns Teva Pharmaceutical Industries

Ownership of Teva Pharmaceutical Industries
Held by institutions69.3%782 institutions; percent of shares outstanding
Held by institutions, of the float69.6%
Held by insiders0.48%percent of shares outstanding
Shares outstanding1.17B
Float1.09Bshares available to trade
Insiders' net purchases, six months+14.46K3 purchases (43.48K shares), 4 sales (29.02K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Teva Pharmaceutical Industries
Shares short27.74Mas of Oct 30, 2026
Percent of float2.39%shares short ÷ float
Percent of shares outstanding2.38%shares short ÷ shares outstanding
Short ratio (days to cover)4.49shares short ÷ average daily volume

Teva Pharmaceutical Industries short interest from FINRA, with its history

Trading figures

Trading figures for Teva Pharmaceutical Industries
Beta0.84movement against the market; 1 moves with it
52-week high$44.57
52-week low$24.01
Average volume, 3 months6.15Mshares a day
Average volume, 10 days8.63Mshares a day

Dates to know

Upcoming and recent dates for Teva Pharmaceutical Industries
Next earnings reportJan 27, 2027the feed's estimate, not confirmed
Ex-dividend dateNov 28, 2017as the feed lists it
Dividend payment dateDec 12, 2017

Questions and answers

What is the analysts' price target for Teva Pharmaceutical Industries (TEVA)?

As reported by the data feed, the mean price target of the 14 analysts covering Teva Pharmaceutical Industries is $50.29, 18.0% above the latest price of $42.62. The highest target is $57.00 and the lowest $42.12. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Teva Pharmaceutical Industries stock?

Of the 15 ratings the data feed reports for the current month, 4 are strong buy, 9 buy, 2 hold, 0 sell and 0 strong sell.

How many Teva Pharmaceutical Industries shares are sold short?

As reported by the data feed, 27.74M shares were sold short, 2.39% of the float as of Oct 30, 2026. At the average daily volume that is 4.49 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Teva Pharmaceutical Industries stock?

As reported by the data feed, institutions hold 69.3% of the shares (782 institutions) and insiders 0.5%. There are 1.17B shares outstanding, of which 1.09B are in the float.

When is Teva Pharmaceutical Industries's next earnings report?

The data feed lists Jan 27, 2027, marked as its estimate rather than a date the company has confirmed. The latest ex-dividend date it lists is Nov 28, 2017.

How much does Teva Pharmaceutical Industries stock move with the market?

Its beta, as reported by the data feed, is 0.84: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $24.01 and $44.57.

Cite this page

Funkfolio, “Teva Pharmaceutical Industries (TEVA) statistics and analyst targets”, data as of 18 November 2026. https://funkfolio.com/stock/TEVA/statistics

Underlying data: Yahoo Finance.